Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$19,190
+$5,394 QoQ
Shares Held
16
+6.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#4,565
of 4,605 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PayPay Securities Corp holds $69,318 across 8 Drug Manufacturers - General names. LLY ranks #1 (27.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
16 | $19,190 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
207 | $11,927 | |
| 3 | JNJ |
Johnson & Johnson
|
46 | $11,682 | |
| 4 | ABBV |
AbbVie Inc.
|
33 | $8,304 | |
| 5 | PFE |
Pfizer Inc
|
255 | $6,140 | |
| 6 | MRK |
Merck & Co., Inc.
|
46 | $5,911 | |
| 7 | AMGN |
Amgen Inc
|
9 | $3,259 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
23 | $2,905 |
All Filings in LLY
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,190 | 16 | Shares | Defined | 2026-07-23 | |
| 2026-03-31 | $13,796 | 15 | Shares | Defined | 2026-04-23 | |
| 2025-12-31 | $21,493 | 20 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $11,445 | 15 | Shares | Defined | 2025-10-21 | |
| 2025-06-30 | $9,354 | 12 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $10,736 | 13 | Shares | Defined | 2025-04-17 | |
| 2024-12-31 | $14,668 | 19 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $20,376 | 23 | Shares | Defined | 2024-11-01 | |
| 2024-06-30 | $13,580 | 15 | Shares | Defined | 2024-08-01 | |
| 2024-03-31 | $18,671 | 24 | Shares | Defined | 2024-04-18 | |
| 2023-12-31 | $13,407 | 23 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $13,428 | 25 | Shares | Defined | 2023-10-31 | |
| No filing history on record for this holder in this stock. | ||||||